This company has been marked as potentially delisted and may not be actively trading. Bellerophon Therapeutics (BLPH) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Bellerophon Therapeutics Short Interest DataBellerophon Therapeutics (BLPH) has a short interest of 66,800 shares. This marks a -26.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 18,907 shares to cover all short positions.Current Short Interest66,800 sharesPrevious Short Interest90,500 sharesChange Vs. Previous Month-26.19%Dollar Volume Sold Short$6.85 thousandShort Interest Ratio0.2 Days to CoverLast Record DateOctober 15, 2023Outstanding Shares12,233,000 sharesPercentage of Shares Shorted0.55%Today's Trading Volume7,027 sharesAverage Trading Volume18,907 sharesToday's Volume Vs. Average37% Short Selling Bellerophon Therapeutics? Sign up to receive the latest short interest report for Bellerophon Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBLPH Short Interest Over TimeBLPH Days to Cover Over TimeBLPH Percentage of Float Shorted Over Time Bellerophon Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202366,800 shares $6.85 thousand -26.2%N/A0.2 $0.10 9/30/202390,500 shares $35.98 thousand -54.2%N/A0.6 $0.40 9/15/2023197,500 shares $82.40 thousand +59.8%N/A1 $0.42 8/31/2023123,600 shares $53.27 thousand -11.3%N/A0.4 $0.43 8/15/2023139,300 shares $55.72 thousand -9.0%N/A0.2 $0.40 7/31/2023153,000 shares $69.00 thousand +64.0%N/A0.3 $0.45 7/15/202393,300 shares $69.88 thousand -57.7%N/A0.2 $0.75 6/30/2023220,300 shares $152.01 thousand -50.3%N/A0.4 $0.69 6/15/2023443,000 shares $312.23 thousand +27.7%N/A0.8 $0.70 5/31/2023347,000 shares $2.40 million +44.3%N/A0.6 $6.91 Get the Latest News and Ratings for BLPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellerophon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2023240,400 shares $2.09 million +2.0%N/A0.2 $8.71 4/30/2023235,600 shares $1.80 million -45.8%N/A0.2 $7.65 4/15/2023434,800 shares $4.78 million -22.3%N/A0.4 $10.99 3/31/2023559,800 shares $4.42 million -40.8%N/A0.5 $7.89 3/15/2023945,100 shares $6.09 million +473.8%N/A0.4 $6.44 2/28/2023164,700 shares $294.81 thousand +6.8%N/A0.1 $1.79 2/15/2023154,200 shares $232.84 thousand +19.5%1.7%0.1 $1.51 1/31/2023129,000 shares $250.26 thousand -48.6%1.4%0.1 $1.94 1/15/2023251,100 shares $607.66 thousand +1,450.0%2.7%0.2 $2.42 12/30/202216,200 shares $14.58 thousand -55.6%0.2%0 $0.90 12/15/202236,500 shares $29.02 thousand +65.2%0.4%1.6 $0.80 11/30/202222,100 shares $22.15 thousand +25.6%0.2%1.6 $1.00 11/15/202217,600 shares $19.54 thousand -36.9%0.2%1.2 $1.11 10/31/202227,900 shares $31.53 thousand +67.1%0.3%1.7 $1.13 10/15/202216,700 shares $17.20 thousand -10.7%0.2%0.8 $1.03 9/30/202218,700 shares $20.38 thousand +1.1%0.2%0.8 $1.09 9/15/202218,500 shares $23.87 thousand -19.6%0.2%0.5 $1.29 8/31/202223,000 shares $29.21 thousand -24.1%0.3%0.6 $1.27 8/15/202230,300 shares $42.42 thousand -24.8%0.3%0.8 $1.40 7/31/202240,300 shares $60.85 thousand +63.2%0.4%0.9 $1.51 7/15/202224,700 shares $31.62 thousand -77.0%0.3%0.5 $1.28 6/30/2022107,200 shares $131.86 thousand +757.6%1.2%1.7 $1.23 6/15/202212,500 shares $11.88 thousand -53.0%0.1%0.2 $0.95 5/31/202226,600 shares $28.20 thousand +12.2%0.3%0.5 $1.06 5/15/202223,700 shares $20.09 thousand -21.0%0.3%0.4 $0.85 4/30/202230,000 shares $38.10 thousand +11.9%0.3%0.6 $1.27 4/15/202226,800 shares $57.08 thousand -42.6%0.3%0.6 $2.13 3/31/202246,700 shares $110.21 thousand -6.8%0.5%1 $2.36 3/15/202250,100 shares $91.18 thousand -2.2%0.6%0.3 $1.82 2/28/202251,200 shares $114.18 thousand -27.0%0.6%0.1 $2.23Crypto Is Pumping Again – Now Comes the Real Opportunity (Ad)This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.Crypto’s Most Powerful Signal Just Triggered - PLUS Claim your $10 in Bitcoin 2/15/202270,100 shares $164.03 thousand +14.5%0.8%0.1 $2.34 1/31/202261,200 shares $145.04 thousand -43.3%0.7%0.1 $2.37 1/15/2022108,000 shares $303.48 thousand -73.9%1.2%0.1 $2.81 12/31/2021413,500 shares $1.28 million +863.9%4.6%0.5 $3.10 12/15/202142,900 shares $101.24 thousand -7.1%0.5%0.1 $2.36 11/30/202146,200 shares $146.92 thousand -11.2%0.5%1.1 $3.18 11/15/202152,000 shares $176.28 thousand +9.5%0.6%1.3 $3.39 10/29/202147,500 shares $168.15 thousand +10.7%0.5%1.2 $3.54 10/15/202142,900 shares $167.31 thousand -21.3%0.5%1.1 $3.90 9/30/202154,500 shares $221.27 thousand -2.9%0.6%1.2 $4.06 9/15/202156,100 shares $215.42 thousand -16.5%0.6%0.7 $3.84 8/31/202167,200 shares $282.24 thousand -18.6%0.7%0.4 $4.20 8/13/202182,500 shares $334.13 thousand -16.9%1.0%0.5 $4.05 7/30/202199,300 shares $413.09 thousand +8.9%1.2%0.6 $4.16 7/15/202191,200 shares $383.95 thousand -28.1%1.1%0.5 $4.21 6/30/2021126,800 shares $613.71 thousand -31.8%1.5%0.7 $4.84 6/15/2021186,000 shares $855.60 thousand +13.6%2.2%1.3 $4.60 5/28/2021163,700 shares $677.72 thousand +4.7%2.0%2.5 $4.14 5/14/2021156,300 shares $598.63 thousand +1.6%1.9%2.3 $3.83 4/30/2021153,800 shares $667.49 thousand -54.8%1.9%1.9 $4.34 4/15/2021340,300 shares $1.51 million +2.8%4.2%4 $4.44 3/31/2021331,100 shares $1.72 million +7.6%4.1%4.1 $5.18 3/15/2021307,800 shares $2.11 million +3.1%4.0%3.7 $6.85 2/26/2021298,700 shares $1.98 million +15.4%3.9%3.9 $6.63 2/12/2021258,800 shares $2.06 million +1.7%3.4%3 $7.95 1/29/2021254,600 shares $1.77 million +0.8%3.0%3.3 $6.94 1/15/2021252,500 shares $1.86 million +0.6%2.9%3.5 $7.36 12/31/2020251,100 shares $1.78 million +4.7%2.9%3.8 $7.09 12/15/2020239,800 shares $1.65 million +2.4%2.8%4 $6.90 11/30/2020234,200 shares $1.57 million +45.7%2.7%4.4 $6.72 11/15/2020160,800 shares $1.29 million -1.2%1.9%3 $8.00 10/30/2020162,800 shares $1.34 million -12.1%1.9%3.5 $8.26 10/15/2020185,100 shares $1.71 million -9.8%2.2%3.3 $9.26 9/30/2020205,300 shares $2.09 million -17.0%2.4%2.7 $10.18 9/15/2020247,400 shares $2.63 million -23.6%2.9%2.2 $10.62 8/31/2020324,000 shares $3.50 million -16.8%3.8%2.4 $10.79 8/14/2020389,500 shares $4.62 million +3.7%4.5%2.3 $11.85 7/31/2020375,600 shares $4.82 million -3.6%4.5%1.5 $12.84 7/15/2020389,800 shares $5.29 million -18.2%7.2%1.4 $13.57 6/30/2020476,600 shares $5.98 million +25.2%8.8%1.5 $12.55 BLPH Short Interest - Frequently Asked Questions What is Bellerophon Therapeutics' current short interest? Short interest is the volume of Bellerophon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 66,800 shares of BLPH short. Learn More on Bellerophon Therapeutics' current short interest. Is Bellerophon Therapeutics' short interest increasing or decreasing? Bellerophon Therapeutics saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 66,800 shares, a decline of 26.2% from the previous total of 90,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bellerophon Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bellerophon Therapeutics: NuCana PLC Sponsored ADR (80.88%), Biophytis S.A. (0.47%), Virpax Pharmaceuticals, Inc. (0.67%), Kiromic BioPharma, Inc. (0.01%), TC Biopharm (Holdings) Plc (176.43%), Vincerx Pharma, Inc. (0.05%), Bon Natural Life Limited (97.97%), Smart for Life, Inc. (0.01%), Navidea Biopharmaceuticals, Inc. (0.00%), Scopus BioPharma Inc. (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Corporation ($2.90 billion), TC Energy Corporation ($2.74 billion), Tractor Supply Company ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Bellerophon Therapeutics stock? Short selling BLPH is an investing strategy that aims to generate trading profit from Bellerophon Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bellerophon Therapeutics? A short squeeze for Bellerophon Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLPH, which in turn drives the price of the stock up even further. How often is Bellerophon Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLPH, twice per month. The most recent reporting period available is October, 15 2023. More Short Interest Resources from MarketBeat Related Companies NuCana Short Interest Biophytis Short Interest Virpax Pharmaceuticals Short Interest Kiromic BioPharma Short Interest TC Biopharm Short Interest Vincerx Pharma Short Interest Bon Natural Life Short Interest Smart for Life Short Interest Navidea Biopharmaceuticals Short Interest Scopus BioPharma Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLPH) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellerophon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellerophon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
